Literature DB >> 21509229

Small Incidental Renal Masses in Adults: Review of the literature.

Mohammed S Al-Marhoon1.   

Abstract

Incidental renal tumours are becoming an important clinical problem that many physicians will need to deal with. A good knowledge of the nature of these tumours and how to manage them is therefore needed. The aim of this paper is to review the literature about incidental renal tumours in adults. Many incidentally discovered small renal tumours (<4 cm) are benign and of low stage, grade and progression potential. The preferred management in young fit patients is open or laparoscopic nephron-sparing surgery. Treatment alternatives include needle-ablative therapies and surveillance in elderly unfit patients. Tumour renal biopsy is encouraged prior to needle-ablative therapy and surveillance. Awareness about incidental renal masses and their management is essential for treating doctors.

Entities:  

Keywords:  Incidental; Renal cell carcinoma; Tumors; renal

Year:  2010        PMID: 21509229      PMCID: PMC3074712     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  32 in total

1.  Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention.

Authors:  Erik Kouba; Angela Smith; Daniel McRackan; Eric M Wallen; Raj S Pruthi
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

2.  Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.

Authors:  Mesut Remzi; Mehmet Ozsoy; Hans-Christoph Klingler; Martin Susani; Matthias Waldert; Christian Seitz; Joerg Schmidbauer; Michael Marberger
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

3.  Evaluation of incidental renal and adrenal masses.

Authors:  J C Higgins; J M Fitzgerald
Journal:  Am Fam Physician       Date:  2001-01-15       Impact factor: 3.292

4.  Global increases in kidney cancer incidence, 1973-1992.

Authors:  A Mathew; S S Devesa; J F Fraumeni; W-H Chow
Journal:  Eur J Cancer Prev       Date:  2002-04       Impact factor: 2.497

5.  Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses.

Authors:  Frank J Rybicki; Kirstin M Shu; Edmund S Cibas; Julia R Fielding; Eric vanSonnenberg; Stuart G Silverman
Journal:  AJR Am J Roentgenol       Date:  2003-05       Impact factor: 3.959

6.  Rising incidence of renal cell cancer in the United States.

Authors:  W H Chow; S S Devesa; J L Warren; J F Fraumeni
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

Review 7.  Renal masses in the adult patient: the role of percutaneous biopsy.

Authors:  Stuart G Silverman; Yu Unn Gan; Koenraad J Mortele; Kemal Tuncali; Edmund S Cibas
Journal:  Radiology       Date:  2006-05-18       Impact factor: 11.105

8.  Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors.

Authors:  Christopher J Weight; Jihad H Kaouk; Nicholas J Hegarty; Erick M Remer; Charles M O'Malley; Brian R Lane; Inderbir S Gill; Andrew C Novick
Journal:  J Urol       Date:  2008-02-20       Impact factor: 7.450

9.  The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses.

Authors:  Beverley A Shannon; Ronald J Cohen; Hildemarie de Bruto; Robert J Davies
Journal:  J Urol       Date:  2008-08-15       Impact factor: 7.450

Review 10.  Histopathology of surgically managed renal tumors: analysis of a contemporary series.

Authors:  David A Duchene; Yair Lotan; Jeffrey A Cadeddu; Arthur I Sagalowsky; Kenneth S Koeneman
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

View more
  1 in total

1.  DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition.

Authors:  Jianbo Zheng; Yanhui Mei; Ping Xiang; Guangsheng Zhai; Ning Zhao; Chuanbing Xu; Min Liu; Zhengsheng Pan; Kai Tang; Dongsheng Jia
Journal:  Cancer Cell Int       Date:  2018-04-10       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.